nodes	percent_of_prediction	percent_of_DWPC	metapath
Hyoscyamine—Dolasetron—CYP3A4—bone cancer	0.0153	0.364	CrCbGaD
Hyoscyamine—Granisetron—CYP3A4—bone cancer	0.014	0.333	CrCbGaD
Hyoscyamine—Cocaine—CYP3A4—bone cancer	0.00664	0.158	CrCbGaD
Hyoscyamine—Ipratropium bromide—CYP3A4—bone cancer	0.00607	0.145	CrCbGaD
Hyoscyamine—Dehydration—Cisplatin—bone cancer	0.00554	0.00579	CcSEcCtD
Hyoscyamine—Rash erythematous—Epirubicin—bone cancer	0.00551	0.00575	CcSEcCtD
Hyoscyamine—Petechiae—Methotrexate—bone cancer	0.00548	0.00572	CcSEcCtD
Hyoscyamine—Hypokalaemia—Cisplatin—bone cancer	0.00543	0.00566	CcSEcCtD
Hyoscyamine—Laryngitis—Doxorubicin—bone cancer	0.00541	0.00565	CcSEcCtD
Hyoscyamine—Feeling hot—Epirubicin—bone cancer	0.00537	0.00561	CcSEcCtD
Hyoscyamine—Ventricular arrhythmia—Doxorubicin—bone cancer	0.00527	0.0055	CcSEcCtD
Hyoscyamine—Speech disorder—Methotrexate—bone cancer	0.00524	0.00547	CcSEcCtD
Hyoscyamine—Stinging—Epirubicin—bone cancer	0.00521	0.00543	CcSEcCtD
Hyoscyamine—Ageusia—Epirubicin—bone cancer	0.00521	0.00543	CcSEcCtD
Hyoscyamine—Petechiae—Epirubicin—bone cancer	0.00513	0.00535	CcSEcCtD
Hyoscyamine—Rash erythematous—Doxorubicin—bone cancer	0.0051	0.00532	CcSEcCtD
Hyoscyamine—Blood disorder—Epirubicin—bone cancer	0.00505	0.00527	CcSEcCtD
Hyoscyamine—Feeling hot—Doxorubicin—bone cancer	0.00497	0.00519	CcSEcCtD
Hyoscyamine—Delirium—Epirubicin—bone cancer	0.0049	0.00512	CcSEcCtD
Hyoscyamine—Ageusia—Doxorubicin—bone cancer	0.00482	0.00503	CcSEcCtD
Hyoscyamine—Stinging—Doxorubicin—bone cancer	0.00482	0.00503	CcSEcCtD
Hyoscyamine—Dysarthria—Methotrexate—bone cancer	0.00476	0.00497	CcSEcCtD
Hyoscyamine—Petechiae—Doxorubicin—bone cancer	0.00474	0.00495	CcSEcCtD
Hyoscyamine—Blood disorder—Doxorubicin—bone cancer	0.00467	0.00488	CcSEcCtD
Hyoscyamine—Ventricular extrasystoles—Epirubicin—bone cancer	0.00467	0.00487	CcSEcCtD
Hyoscyamine—Respiratory failure—Methotrexate—bone cancer	0.00459	0.00479	CcSEcCtD
Hyoscyamine—Delirium—Doxorubicin—bone cancer	0.00454	0.00474	CcSEcCtD
Hyoscyamine—Acute coronary syndrome—Cisplatin—bone cancer	0.00453	0.00473	CcSEcCtD
Hyoscyamine—Myocardial infarction—Cisplatin—bone cancer	0.0045	0.0047	CcSEcCtD
Hyoscyamine—Conjunctivitis—Cisplatin—bone cancer	0.00447	0.00466	CcSEcCtD
Hyoscyamine—Dysarthria—Epirubicin—bone cancer	0.00446	0.00465	CcSEcCtD
Hyoscyamine—Depressed level of consciousness—Methotrexate—bone cancer	0.00435	0.00454	CcSEcCtD
Hyoscyamine—Ventricular extrasystoles—Doxorubicin—bone cancer	0.00432	0.00451	CcSEcCtD
Hyoscyamine—Skin exfoliation—Methotrexate—bone cancer	0.0043	0.00449	CcSEcCtD
Hyoscyamine—Ventricular tachycardia—Epirubicin—bone cancer	0.00422	0.0044	CcSEcCtD
Hyoscyamine—Bradycardia—Cisplatin—bone cancer	0.0042	0.00438	CcSEcCtD
Hyoscyamine—Injection site reaction—Epirubicin—bone cancer	0.00419	0.00438	CcSEcCtD
Hyoscyamine—Dermatitis contact—Epirubicin—bone cancer	0.00417	0.00435	CcSEcCtD
Hyoscyamine—Dysarthria—Doxorubicin—bone cancer	0.00413	0.00431	CcSEcCtD
Hyoscyamine—Coma—Methotrexate—bone cancer	0.00412	0.0043	CcSEcCtD
Hyoscyamine—Skin exfoliation—Epirubicin—bone cancer	0.00403	0.0042	CcSEcCtD
Hyoscyamine—Pulmonary oedema—Methotrexate—bone cancer	0.00401	0.00419	CcSEcCtD
Hyoscyamine—Blood urea increased—Epirubicin—bone cancer	0.00398	0.00416	CcSEcCtD
Hyoscyamine—Ventricular tachycardia—Doxorubicin—bone cancer	0.0039	0.00407	CcSEcCtD
Hyoscyamine—Dry eye—Epirubicin—bone cancer	0.0039	0.00407	CcSEcCtD
Hyoscyamine—Injection site reaction—Doxorubicin—bone cancer	0.00388	0.00405	CcSEcCtD
Hyoscyamine—Dermatitis contact—Doxorubicin—bone cancer	0.00386	0.00403	CcSEcCtD
Hyoscyamine—Coma—Epirubicin—bone cancer	0.00385	0.00402	CcSEcCtD
Hyoscyamine—Rash maculo-papular—Epirubicin—bone cancer	0.00383	0.004	CcSEcCtD
Hyoscyamine—Flushing—Cisplatin—bone cancer	0.00383	0.004	CcSEcCtD
Hyoscyamine—Pulmonary oedema—Epirubicin—bone cancer	0.00375	0.00392	CcSEcCtD
Hyoscyamine—Skin exfoliation—Doxorubicin—bone cancer	0.00373	0.00389	CcSEcCtD
Hyoscyamine—Hypertonia—Epirubicin—bone cancer	0.0037	0.00386	CcSEcCtD
Hyoscyamine—Arrhythmia—Cisplatin—bone cancer	0.00368	0.00385	CcSEcCtD
Hyoscyamine—Blood urea increased—Doxorubicin—bone cancer	0.00368	0.00385	CcSEcCtD
Hyoscyamine—Dry eye—Doxorubicin—bone cancer	0.0036	0.00376	CcSEcCtD
Hyoscyamine—Erythema—Cisplatin—bone cancer	0.00359	0.00375	CcSEcCtD
Hyoscyamine—Coma—Doxorubicin—bone cancer	0.00357	0.00372	CcSEcCtD
Hyoscyamine—Rash maculo-papular—Doxorubicin—bone cancer	0.00355	0.0037	CcSEcCtD
Hyoscyamine—Pulmonary oedema—Doxorubicin—bone cancer	0.00347	0.00363	CcSEcCtD
Hyoscyamine—Hypertonia—Doxorubicin—bone cancer	0.00342	0.00357	CcSEcCtD
Hyoscyamine—Eczema—Epirubicin—bone cancer	0.00341	0.00356	CcSEcCtD
Hyoscyamine—Eye pain—Epirubicin—bone cancer	0.00339	0.00354	CcSEcCtD
Hyoscyamine—Vision blurred—Cisplatin—bone cancer	0.00338	0.00353	CcSEcCtD
Hyoscyamine—Lethargy—Methotrexate—bone cancer	0.00334	0.00348	CcSEcCtD
Hyoscyamine—Osteoarthritis—Methotrexate—bone cancer	0.00327	0.00341	CcSEcCtD
Hyoscyamine—Eczema—Doxorubicin—bone cancer	0.00315	0.00329	CcSEcCtD
Hyoscyamine—Eye pain—Doxorubicin—bone cancer	0.00314	0.00328	CcSEcCtD
Hyoscyamine—Hypoglycaemia—Epirubicin—bone cancer	0.00314	0.00327	CcSEcCtD
Hyoscyamine—Lethargy—Epirubicin—bone cancer	0.00312	0.00326	CcSEcCtD
Hyoscyamine—Irritability—Methotrexate—bone cancer	0.00312	0.00326	CcSEcCtD
Hyoscyamine—Convulsion—Cisplatin—bone cancer	0.00311	0.00325	CcSEcCtD
Hyoscyamine—Ataxia—Methotrexate—bone cancer	0.00308	0.00321	CcSEcCtD
Hyoscyamine—Hyponatraemia—Epirubicin—bone cancer	0.00307	0.00321	CcSEcCtD
Hyoscyamine—Osteoarthritis—Epirubicin—bone cancer	0.00306	0.0032	CcSEcCtD
Hyoscyamine—Anxiety—Cisplatin—bone cancer	0.00305	0.00318	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Cisplatin—bone cancer	0.00293	0.00306	CcSEcCtD
Hyoscyamine—Oedema—Cisplatin—bone cancer	0.00293	0.00306	CcSEcCtD
Hyoscyamine—Cardiac arrest—Epirubicin—bone cancer	0.00291	0.00304	CcSEcCtD
Hyoscyamine—Hypoglycaemia—Doxorubicin—bone cancer	0.0029	0.00303	CcSEcCtD
Hyoscyamine—Lethargy—Doxorubicin—bone cancer	0.00289	0.00302	CcSEcCtD
Hyoscyamine—Ataxia—Epirubicin—bone cancer	0.00288	0.003	CcSEcCtD
Hyoscyamine—Tachycardia—Cisplatin—bone cancer	0.00286	0.00298	CcSEcCtD
Hyoscyamine—Dehydration—Epirubicin—bone cancer	0.00285	0.00297	CcSEcCtD
Hyoscyamine—Hyponatraemia—Doxorubicin—bone cancer	0.00284	0.00297	CcSEcCtD
Hyoscyamine—Osteoarthritis—Doxorubicin—bone cancer	0.00283	0.00296	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Cisplatin—bone cancer	0.00283	0.00296	CcSEcCtD
Hyoscyamine—Dry skin—Epirubicin—bone cancer	0.00281	0.00293	CcSEcCtD
Hyoscyamine—Hypokalaemia—Epirubicin—bone cancer	0.00279	0.00291	CcSEcCtD
Hyoscyamine—Hypotension—Cisplatin—bone cancer	0.00274	0.00286	CcSEcCtD
Hyoscyamine—Cardiac arrest—Doxorubicin—bone cancer	0.00269	0.00281	CcSEcCtD
Hyoscyamine—Abdominal distension—Epirubicin—bone cancer	0.00266	0.00278	CcSEcCtD
Hyoscyamine—Ataxia—Doxorubicin—bone cancer	0.00266	0.00278	CcSEcCtD
Hyoscyamine—Dysphagia—Epirubicin—bone cancer	0.00265	0.00276	CcSEcCtD
Hyoscyamine—Dysuria—Methotrexate—bone cancer	0.00264	0.00276	CcSEcCtD
Hyoscyamine—Dehydration—Doxorubicin—bone cancer	0.00263	0.00275	CcSEcCtD
Hyoscyamine—Dyspnoea—Cisplatin—bone cancer	0.00261	0.00273	CcSEcCtD
Hyoscyamine—Erectile dysfunction—Methotrexate—bone cancer	0.0026	0.00272	CcSEcCtD
Hyoscyamine—Dry skin—Doxorubicin—bone cancer	0.0026	0.00271	CcSEcCtD
Hyoscyamine—Hypokalaemia—Doxorubicin—bone cancer	0.00258	0.00269	CcSEcCtD
Hyoscyamine—Angina pectoris—Epirubicin—bone cancer	0.00258	0.00269	CcSEcCtD
Hyoscyamine—Drowsiness—Methotrexate—bone cancer	0.00252	0.00263	CcSEcCtD
Hyoscyamine—Depression—Methotrexate—bone cancer	0.00251	0.00262	CcSEcCtD
Hyoscyamine—Pain—Cisplatin—bone cancer	0.00251	0.00262	CcSEcCtD
Hyoscyamine—Dysuria—Epirubicin—bone cancer	0.00247	0.00258	CcSEcCtD
Hyoscyamine—Abdominal distension—Doxorubicin—bone cancer	0.00246	0.00257	CcSEcCtD
Hyoscyamine—Conjunctivitis—Methotrexate—bone cancer	0.00245	0.00256	CcSEcCtD
Hyoscyamine—Dysphagia—Doxorubicin—bone cancer	0.00245	0.00256	CcSEcCtD
Hyoscyamine—Sweating—Methotrexate—bone cancer	0.00242	0.00252	CcSEcCtD
Hyoscyamine—Feeling abnormal—Cisplatin—bone cancer	0.00241	0.00252	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Epirubicin—bone cancer	0.00239	0.00249	CcSEcCtD
Hyoscyamine—Angina pectoris—Doxorubicin—bone cancer	0.00238	0.00249	CcSEcCtD
Hyoscyamine—Drowsiness—Epirubicin—bone cancer	0.00236	0.00246	CcSEcCtD
Hyoscyamine—Body temperature increased—Cisplatin—bone cancer	0.00232	0.00242	CcSEcCtD
Hyoscyamine—Conjunctivitis—Epirubicin—bone cancer	0.00229	0.00239	CcSEcCtD
Hyoscyamine—Dysuria—Doxorubicin—bone cancer	0.00229	0.00239	CcSEcCtD
Hyoscyamine—Sweating—Epirubicin—bone cancer	0.00226	0.00236	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Doxorubicin—bone cancer	0.00221	0.00231	CcSEcCtD
Hyoscyamine—Drowsiness—Doxorubicin—bone cancer	0.00218	0.00228	CcSEcCtD
Hyoscyamine—Hypersensitivity—Cisplatin—bone cancer	0.00216	0.00225	CcSEcCtD
Hyoscyamine—Bradycardia—Epirubicin—bone cancer	0.00216	0.00225	CcSEcCtD
Hyoscyamine—Conjunctivitis—Doxorubicin—bone cancer	0.00212	0.00221	CcSEcCtD
Hyoscyamine—Asthenia—Cisplatin—bone cancer	0.0021	0.00219	CcSEcCtD
Hyoscyamine—Sweating—Doxorubicin—bone cancer	0.00209	0.00218	CcSEcCtD
Hyoscyamine—Diarrhoea—Cisplatin—bone cancer	0.002	0.00209	CcSEcCtD
Hyoscyamine—Bradycardia—Doxorubicin—bone cancer	0.00199	0.00208	CcSEcCtD
Hyoscyamine—Mental disorder—Methotrexate—bone cancer	0.00198	0.00207	CcSEcCtD
Hyoscyamine—Erythema—Methotrexate—bone cancer	0.00197	0.00206	CcSEcCtD
Hyoscyamine—Flushing—Epirubicin—bone cancer	0.00197	0.00205	CcSEcCtD
Hyoscyamine—Dysgeusia—Methotrexate—bone cancer	0.00193	0.00201	CcSEcCtD
Hyoscyamine—Arrhythmia—Epirubicin—bone cancer	0.00189	0.00197	CcSEcCtD
Hyoscyamine—Vomiting—Cisplatin—bone cancer	0.00186	0.00194	CcSEcCtD
Hyoscyamine—Vision blurred—Methotrexate—bone cancer	0.00186	0.00194	CcSEcCtD
Hyoscyamine—Mental disorder—Epirubicin—bone cancer	0.00186	0.00194	CcSEcCtD
Hyoscyamine—Rash—Cisplatin—bone cancer	0.00185	0.00193	CcSEcCtD
Hyoscyamine—Dermatitis—Cisplatin—bone cancer	0.00185	0.00193	CcSEcCtD
Hyoscyamine—Erythema—Epirubicin—bone cancer	0.00184	0.00192	CcSEcCtD
Hyoscyamine—Flushing—Doxorubicin—bone cancer	0.00182	0.0019	CcSEcCtD
Hyoscyamine—Tension—Epirubicin—bone cancer	0.00181	0.00189	CcSEcCtD
Hyoscyamine—Dysgeusia—Epirubicin—bone cancer	0.00181	0.00188	CcSEcCtD
Hyoscyamine—Nervousness—Epirubicin—bone cancer	0.00179	0.00187	CcSEcCtD
Hyoscyamine—Vertigo—Methotrexate—bone cancer	0.00177	0.00185	CcSEcCtD
Hyoscyamine—Arrhythmia—Doxorubicin—bone cancer	0.00175	0.00183	CcSEcCtD
Hyoscyamine—Nausea—Cisplatin—bone cancer	0.00174	0.00182	CcSEcCtD
Hyoscyamine—Vision blurred—Epirubicin—bone cancer	0.00174	0.00181	CcSEcCtD
Hyoscyamine—Mental disorder—Doxorubicin—bone cancer	0.00172	0.00179	CcSEcCtD
Hyoscyamine—Convulsion—Methotrexate—bone cancer	0.00171	0.00178	CcSEcCtD
Hyoscyamine—Erythema—Doxorubicin—bone cancer	0.00171	0.00178	CcSEcCtD
Hyoscyamine—Agitation—Epirubicin—bone cancer	0.00169	0.00177	CcSEcCtD
Hyoscyamine—Chest pain—Methotrexate—bone cancer	0.00168	0.00175	CcSEcCtD
Hyoscyamine—Tension—Doxorubicin—bone cancer	0.00167	0.00175	CcSEcCtD
Hyoscyamine—Dysgeusia—Doxorubicin—bone cancer	0.00167	0.00174	CcSEcCtD
Hyoscyamine—Nervousness—Doxorubicin—bone cancer	0.00166	0.00173	CcSEcCtD
Hyoscyamine—Vertigo—Epirubicin—bone cancer	0.00166	0.00173	CcSEcCtD
Hyoscyamine—Syncope—Epirubicin—bone cancer	0.00165	0.00173	CcSEcCtD
Hyoscyamine—Palpitations—Epirubicin—bone cancer	0.00163	0.0017	CcSEcCtD
Hyoscyamine—Confusional state—Methotrexate—bone cancer	0.00162	0.00169	CcSEcCtD
Hyoscyamine—Loss of consciousness—Epirubicin—bone cancer	0.00162	0.00169	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Methotrexate—bone cancer	0.00161	0.00168	CcSEcCtD
Hyoscyamine—Vision blurred—Doxorubicin—bone cancer	0.00161	0.00168	CcSEcCtD
Hyoscyamine—Convulsion—Epirubicin—bone cancer	0.0016	0.00167	CcSEcCtD
Hyoscyamine—Chest pain—Epirubicin—bone cancer	0.00157	0.00164	CcSEcCtD
Hyoscyamine—Agitation—Doxorubicin—bone cancer	0.00157	0.00164	CcSEcCtD
Hyoscyamine—Anxiety—Epirubicin—bone cancer	0.00156	0.00163	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Methotrexate—bone cancer	0.00155	0.00162	CcSEcCtD
Hyoscyamine—Dry mouth—Epirubicin—bone cancer	0.00154	0.0016	CcSEcCtD
Hyoscyamine—Vertigo—Doxorubicin—bone cancer	0.00153	0.0016	CcSEcCtD
Hyoscyamine—Syncope—Doxorubicin—bone cancer	0.00153	0.0016	CcSEcCtD
Hyoscyamine—Confusional state—Epirubicin—bone cancer	0.00152	0.00158	CcSEcCtD
Hyoscyamine—Palpitations—Doxorubicin—bone cancer	0.00151	0.00157	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Epirubicin—bone cancer	0.0015	0.00157	CcSEcCtD
Hyoscyamine—Oedema—Epirubicin—bone cancer	0.0015	0.00157	CcSEcCtD
Hyoscyamine—Hypotension—Methotrexate—bone cancer	0.0015	0.00157	CcSEcCtD
Hyoscyamine—Loss of consciousness—Doxorubicin—bone cancer	0.0015	0.00156	CcSEcCtD
Hyoscyamine—Shock—Epirubicin—bone cancer	0.00148	0.00155	CcSEcCtD
Hyoscyamine—Convulsion—Doxorubicin—bone cancer	0.00148	0.00154	CcSEcCtD
Hyoscyamine—Tachycardia—Epirubicin—bone cancer	0.00147	0.00153	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Epirubicin—bone cancer	0.00145	0.00152	CcSEcCtD
Hyoscyamine—Insomnia—Methotrexate—bone cancer	0.00145	0.00152	CcSEcCtD
Hyoscyamine—Chest pain—Doxorubicin—bone cancer	0.00145	0.00152	CcSEcCtD
Hyoscyamine—Anxiety—Doxorubicin—bone cancer	0.00145	0.00151	CcSEcCtD
Hyoscyamine—Dyspnoea—Methotrexate—bone cancer	0.00143	0.0015	CcSEcCtD
Hyoscyamine—Somnolence—Methotrexate—bone cancer	0.00143	0.00149	CcSEcCtD
Hyoscyamine—Dry mouth—Doxorubicin—bone cancer	0.00142	0.00148	CcSEcCtD
Hyoscyamine—Dyspepsia—Methotrexate—bone cancer	0.00142	0.00148	CcSEcCtD
Hyoscyamine—Hypotension—Epirubicin—bone cancer	0.00141	0.00147	CcSEcCtD
Hyoscyamine—Confusional state—Doxorubicin—bone cancer	0.0014	0.00147	CcSEcCtD
Hyoscyamine—Oedema—Doxorubicin—bone cancer	0.00139	0.00145	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Doxorubicin—bone cancer	0.00139	0.00145	CcSEcCtD
Hyoscyamine—Fatigue—Methotrexate—bone cancer	0.00139	0.00145	CcSEcCtD
Hyoscyamine—Pain—Methotrexate—bone cancer	0.00137	0.00144	CcSEcCtD
Hyoscyamine—Shock—Doxorubicin—bone cancer	0.00137	0.00143	CcSEcCtD
Hyoscyamine—Insomnia—Epirubicin—bone cancer	0.00136	0.00142	CcSEcCtD
Hyoscyamine—Tachycardia—Doxorubicin—bone cancer	0.00136	0.00142	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Doxorubicin—bone cancer	0.00135	0.0014	CcSEcCtD
Hyoscyamine—Dyspnoea—Epirubicin—bone cancer	0.00134	0.0014	CcSEcCtD
Hyoscyamine—Somnolence—Epirubicin—bone cancer	0.00134	0.0014	CcSEcCtD
Hyoscyamine—Feeling abnormal—Methotrexate—bone cancer	0.00132	0.00138	CcSEcCtD
Hyoscyamine—Dyspepsia—Epirubicin—bone cancer	0.00132	0.00138	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Methotrexate—bone cancer	0.00131	0.00137	CcSEcCtD
Hyoscyamine—Hypotension—Doxorubicin—bone cancer	0.0013	0.00136	CcSEcCtD
Hyoscyamine—Fatigue—Epirubicin—bone cancer	0.0013	0.00135	CcSEcCtD
Hyoscyamine—Pain—Epirubicin—bone cancer	0.00129	0.00134	CcSEcCtD
Hyoscyamine—Constipation—Epirubicin—bone cancer	0.00129	0.00134	CcSEcCtD
Hyoscyamine—Urticaria—Methotrexate—bone cancer	0.00128	0.00133	CcSEcCtD
Hyoscyamine—Abdominal pain—Methotrexate—bone cancer	0.00127	0.00133	CcSEcCtD
Hyoscyamine—Body temperature increased—Methotrexate—bone cancer	0.00127	0.00133	CcSEcCtD
Hyoscyamine—Insomnia—Doxorubicin—bone cancer	0.00126	0.00131	CcSEcCtD
Hyoscyamine—Dyspnoea—Doxorubicin—bone cancer	0.00124	0.0013	CcSEcCtD
Hyoscyamine—Feeling abnormal—Epirubicin—bone cancer	0.00124	0.00129	CcSEcCtD
Hyoscyamine—Somnolence—Doxorubicin—bone cancer	0.00124	0.00129	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Epirubicin—bone cancer	0.00123	0.00128	CcSEcCtD
Hyoscyamine—Dyspepsia—Doxorubicin—bone cancer	0.00123	0.00128	CcSEcCtD
Hyoscyamine—Fatigue—Doxorubicin—bone cancer	0.0012	0.00125	CcSEcCtD
Hyoscyamine—Urticaria—Epirubicin—bone cancer	0.0012	0.00125	CcSEcCtD
Hyoscyamine—Constipation—Doxorubicin—bone cancer	0.00119	0.00124	CcSEcCtD
Hyoscyamine—Pain—Doxorubicin—bone cancer	0.00119	0.00124	CcSEcCtD
Hyoscyamine—Body temperature increased—Epirubicin—bone cancer	0.00119	0.00124	CcSEcCtD
Hyoscyamine—Abdominal pain—Epirubicin—bone cancer	0.00119	0.00124	CcSEcCtD
Hyoscyamine—Hypersensitivity—Methotrexate—bone cancer	0.00118	0.00124	CcSEcCtD
Hyoscyamine—Asthenia—Methotrexate—bone cancer	0.00115	0.0012	CcSEcCtD
Hyoscyamine—Feeling abnormal—Doxorubicin—bone cancer	0.00115	0.0012	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Doxorubicin—bone cancer	0.00114	0.00119	CcSEcCtD
Hyoscyamine—Pruritus—Methotrexate—bone cancer	0.00114	0.00119	CcSEcCtD
Hyoscyamine—Hypersensitivity—Epirubicin—bone cancer	0.00111	0.00116	CcSEcCtD
Hyoscyamine—Urticaria—Doxorubicin—bone cancer	0.00111	0.00115	CcSEcCtD
Hyoscyamine—Abdominal pain—Doxorubicin—bone cancer	0.0011	0.00115	CcSEcCtD
Hyoscyamine—Body temperature increased—Doxorubicin—bone cancer	0.0011	0.00115	CcSEcCtD
Hyoscyamine—Diarrhoea—Methotrexate—bone cancer	0.0011	0.00115	CcSEcCtD
Hyoscyamine—Asthenia—Epirubicin—bone cancer	0.00108	0.00113	CcSEcCtD
Hyoscyamine—Pruritus—Epirubicin—bone cancer	0.00106	0.00111	CcSEcCtD
Hyoscyamine—Dizziness—Methotrexate—bone cancer	0.00106	0.00111	CcSEcCtD
Hyoscyamine—Diarrhoea—Epirubicin—bone cancer	0.00103	0.00107	CcSEcCtD
Hyoscyamine—Hypersensitivity—Doxorubicin—bone cancer	0.00103	0.00107	CcSEcCtD
Hyoscyamine—Vomiting—Methotrexate—bone cancer	0.00102	0.00107	CcSEcCtD
Hyoscyamine—Rash—Methotrexate—bone cancer	0.00101	0.00106	CcSEcCtD
Hyoscyamine—Dermatitis—Methotrexate—bone cancer	0.00101	0.00106	CcSEcCtD
Hyoscyamine—Headache—Methotrexate—bone cancer	0.00101	0.00105	CcSEcCtD
Hyoscyamine—Asthenia—Doxorubicin—bone cancer	0.000999	0.00104	CcSEcCtD
Hyoscyamine—Dizziness—Epirubicin—bone cancer	0.000995	0.00104	CcSEcCtD
Hyoscyamine—Pruritus—Doxorubicin—bone cancer	0.000985	0.00103	CcSEcCtD
Hyoscyamine—Vomiting—Epirubicin—bone cancer	0.000957	0.000999	CcSEcCtD
Hyoscyamine—Nausea—Methotrexate—bone cancer	0.000955	0.000997	CcSEcCtD
Hyoscyamine—Diarrhoea—Doxorubicin—bone cancer	0.000953	0.000994	CcSEcCtD
Hyoscyamine—Rash—Epirubicin—bone cancer	0.000949	0.00099	CcSEcCtD
Hyoscyamine—Dermatitis—Epirubicin—bone cancer	0.000948	0.000989	CcSEcCtD
Hyoscyamine—Headache—Epirubicin—bone cancer	0.000943	0.000984	CcSEcCtD
Hyoscyamine—Dizziness—Doxorubicin—bone cancer	0.000921	0.000961	CcSEcCtD
Hyoscyamine—Nausea—Epirubicin—bone cancer	0.000894	0.000933	CcSEcCtD
Hyoscyamine—Vomiting—Doxorubicin—bone cancer	0.000885	0.000924	CcSEcCtD
Hyoscyamine—Rash—Doxorubicin—bone cancer	0.000878	0.000916	CcSEcCtD
Hyoscyamine—Dermatitis—Doxorubicin—bone cancer	0.000877	0.000915	CcSEcCtD
Hyoscyamine—Headache—Doxorubicin—bone cancer	0.000872	0.00091	CcSEcCtD
Hyoscyamine—Nausea—Doxorubicin—bone cancer	0.000827	0.000863	CcSEcCtD
